Proposal Brief
Industry
Pharmaceuticals
Sub Industry
Deal Size
INR 600 - 700 Cr
Preferred Location
India
Region
Across India
Open for Distressed Assets
Yes
Target Requirement
The target should be engaged in API business.
Preferable product portfolio including but not limited to -
- Atorvastatin,
- Rosuvastatin,
- UDCA,
- Felbamate,
- Artemether,
- Lumefantrine,
- Oncology APIs;
- APIs catering to various therapuetic segments.
